Akums Drugs & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 360.80 | 371.25 | 360.47 |
| Operating Expense | 311.03 | 303.38 | 285.28 |
| Net Profit | 27.59 | 41.17 | 50.37 |
| Net Profit Margin | 7.65 | 11.09 | 13.97 |
| Earning Per Share | 1.80 | 2.69 | 3.38 |
| EBIDTA | 48.57 | 67.20 | 77.65 |
| Effective Tax Rate | 16.60 | 19.24 | 18.23 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 360.80 |
| Operating Expense | 311.03 |
| Net Profit | 27.59 |
| Net Profit Margin | 7.65 |
| Earning Per Share | 1.80 |
| EBIDTA | 48.57 |
| Effective Tax Rate | 16.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,444.12 | 1,286.83 | 1,162.06 |
| Operating Expenses Annual | 1,570.78 | 1,044.95 | 1,524.10 |
| Operating Profit Annual | -51.93 | 193.50 | -303.56 |
| Interest Annual | 18.31 | 13.18 | 3.65 |
| Depreciation | 31.76 | 29.33 | 24.74 |
| Net Profit Annual | -165.45 | 125.43 | -381.78 |
| Tax Annual | 62.52 | 24.89 | 46.80 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,444.12 |
| Operating Expenses Annual | 1,570.78 |
| Operating Profit Annual | -51.93 |
| Interest Annual | 18.31 |
| Depreciation | 31.76 |
| Net Profit Annual | -165.45 |
| Tax Annual | 62.52 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 7.23 | 25.49 | 0.15 |
| Cash Flow from Operations | 247.91 | 94.01 | 228.31 |
| Cash Flow from Investing | -165.44 | -202.17 | -297.96 |
| Cash Flow from Financing | -20.74 | 89.90 | 94.99 |
| Cash Flow at the End | 68.96 | 7.23 | 25.49 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 7.23 |
| Cash Flow from Operations | 247.91 |
| Cash Flow from Investing | -165.44 |
| Cash Flow from Financing | -20.74 |
| Cash Flow at the End | 68.96 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -2.25 | 26.27 | -26.12 |
| PBIT Margin (%) | -4.52 | 23.94 | -28.51 |
| PBT Margin (%) | -4.27 | 22.12 | -20.70 |
| Net PROFIT Margin (%) | -11.46 | 9.75 | -32.85 |
| Return On Networth / Equity (%) | -69.32 | 92.77 | -101.46 |
| Return On Networth /Employed (%) | -3.93 | 21.17 | -25.83 |
| Return On Assets (%) | -9.97 | 8.58 | -29.90 |
| Total Debt / Equity (X) | 0.82 | 0.57 | 0.22 |
| Asset Turnover Ratio (%) | 0.87 | 0.88 | 0.91 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -2.25 |
| PBIT Margin (%) | -4.52 |
| PBT Margin (%) | -4.27 |
| Net PROFIT Margin (%) | -11.46 |
| Return On Networth / Equity (%) | -69.32 |
| Return On Networth /Employed (%) | -3.93 |
| Return On Assets (%) | -9.97 |
| Total Debt / Equity (X) | 0.82 |
| Asset Turnover Ratio (%) | 0.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 298.57 | 253.27 | 233.50 |
| Total Current Assets Annual | 533.14 | 521.08 | 555.16 |
| Non Current Assets Annual | 1,562.18 | 1,373.13 | 1,258.79 |
| Total Shareholders Funds Annual | 143.88 | 311.50 | 185.54 |
| Total Assets Annual | 2,095.43 | 1,894.21 | 1,813.95 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 298.57 |
| Total Current Assets Annual | 533.14 |
| Non Current Assets Annual | 1,562.18 |
| Total Shareholders Funds Annual | 143.88 |
| Total Assets Annual | 2,095.43 |
EPS (INR)
Expected
9.64
Reported
9.64
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 2.58%
